论文部分内容阅读
目的:分析甲巯咪唑治疗SH合并PAF的临床疗效。方法:对照组:服用富马酸比索洛尔,剂量为6mg/d;观察组:服用富马酸比索洛尔以及甲巯咪唑,剂量分别为6mg/d、5.5mg/d。结果:对照组的TSH水平、FT3以及FT4水平与治疗前的水平相比,没有显著性差异(P>0.05);观察组的FT4水平明显下降(P<0.05),TSH水平明显升高(P<0.05)。结论:在治疗SH合并PAF时利用甲巯咪唑能够显著改善疗效,可在临床中使用。
Objective: To analyze the clinical efficacy of methimazole in the treatment of SH combined with PAF. METHODS: The control group: Bisoprolol fumarate at a dose of 6 mg / d. The observation group: bisoprolol fumarate and methimazole at a dose of 6 mg / d and 5.5 mg / d respectively. Results: There was no significant difference in the level of TSH, FT3 and FT4 between the two groups (P> 0.05), the level of FT4 in the control group was significantly decreased (P <0.05) and the level of TSH was significantly increased <0.05). Conclusion: The use of methimazole in the treatment of SH combined with PAF can significantly improve the efficacy, which can be used clinically.